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The Role of Toxicological Interactions in
Lung Injury
by H. R Witschi* and R J. Hakkinen*
Interactions between two or more toxic agents can produce lung damage by chemical-chemical
interactions, chemical-receptor interactions or by modification, by a first agent, of the cell and
tissue response to a second agent. Interactions may occur by simultaneous exposure and if
exposure to the two agents is separated in time. Chemical-chemical interactions have been mostly
studied in the toxicology of air pollutants, where it was shown that the untoward effect of certain
oxidants may be enhanced in the presence of other aerosols. Interactions at the receptor site have
been found in isolated perfused lung experiments. Oxygen tolerance may be an example, when
pre-exposure to one concentration of oxygen mitigates later exposure to 100% oxygen by
modifying cellular and enzymatic composition of the lung. Damage of the alveolar zone by the
antioxidant butylated hydroxytoluene (BHT) can be greatly enhanced by subsequent exposure to
oxygen concentration which, otherwise, would have little if any demonstrable effect. The
synergistic interaction between BHT and oxygen results in a resulting interstitial pulmonary
fibrosis. Acute or chronic lung disease may then be caused not only by one agent, but very likely
in many instances by the interaction of several agents.
Introduction
Toxicological interactions have been broadly defined
as "a circumstance in which exposure to two or more
chemicals results in a qualitatively or quantitatively
altered biological response relative to that predicted
from the action of a single chemical. The multiple
chemical exposures may be simultaneous or sequential
in time and the altered response may be greater or
smaller in magnitude" (1).
Ifexposuretotwo or morechemicals occurssimultane-
ously, we may expect a modified biological response if
the two agents have the potential to react directly with
one another. The action of one agent may be cancelled
by the other (neutralization reactions, chelation of
heavy metals), or two agents may react with each other
to form a more toxic species (nitrosamines from second-
ary amines and nitrites). Another mechanism involves
competition between chemicals at their target sites
which maybethemolecularsiteofabsorption, activation,
detoxification, injurious action or excretion.
It is important to recognize that a modified biological
response may also occur if exposure to two agents is
separated in time. Induction ofmixed function oxidases
is one ofthe best studied examples. Pretreatment with
or inadvertent exposure to a variety of agents will in
many tissues profoundly modify the response to a
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second chemical (2). Interactions of this type are most
often investigated and interpreted in terms of altered
metabolic pathways. Examples include potentiation of
haloalkane-induced liver necrosis by ketogenic agents
(3), the shift of 4-ipomeanol toxicity from lung to liver
(4) or protection against chemical carcinogenesis by
various dietary regimens (5). Chemicals may also alter
cell proliferation or produce shifts in cell-age distribu-
tion and alter the biological response for example to
ionizingradiation(6). Othersinduceirreversible changes
intargetcellswhichthenbecomeenhanced orexpressed
following exposure to a second agent. This is the case in
two-stage carcinogenesis (7). We may thus label this
type of interaction, which does not necessarily require
simultaneous exposure to two or more chemicals, as
interactionsinvolvingalteredcellandtissueresponsiveness.
All three types of interaction mentioned above
-chemical-chemical, chemical-receptorandalteredcell
and tissue responsiveness-may play a role in the
pathogenesis of acute and chronic lung disease. This
will be illustrated with selected examples from the
literature.
Interactions as a Result
of Simultaneous Exposure
Chemical-Chemical Interactions
AirPollutants. The irritating effects ofSO2, the
second most abundant air pollutant, are greatly en-WITSCHI AND HAKKINEN
hanced if guinea pigs are exposed simultaneously to
aqueous aerosols of various salts soluble in water (8,9).
Both the solubility of SO2 in a given aerosol droplet
and the ability ofthe droplet to catalyze the oxidation of
S02to H2SO4play arole inincreasing airwayresistance.
An aerosol in which SO2 is insoluble (e.g., iron oxide
fume, activatedcarbon) doesnotpotentiatetheresponse
to SO2 while potentiation is readily demonstrable by
exposure to aerosols in which H2SO4 is soluble (e.g.,
sodium or potassium chloride, ammonium thiocyanate,
soluble salts of manganese, iron and vanadium).
The particle size of an aerosol also plays a role. For
example, a synergistic increase in guinea pig airway
resistance was observed when sodium chloride particles
with 0.2 pum diameter were combined with SO2, but not
when particles had a diameter of2.5 ,um (10). The same
study also showed a greater than additive increase in
guinea pig airway resistance when particles of sulfuric
acid mist of 0.8 ,um, but not of 2.5 ,um, diameter were
combined with SO2.
Aerosol-gas interactions were also examined by Last
et al. (11,12). Biochemical changes in the lungs
of rats (DNA, RNA and protein content and activi-
ties of various lysosomal enzymes) exposed to 03 and
a H2SO4 aerosol exceeded the sum of the response
induced by either agent alone. Rats exposed to an 03
and H2SO4 mixture showed a synergistic increase
in the rate of mucus glycoprotein secretion from
tracheal explants (13). LeMesurier and co-workers (14)
found that rats exposed to a combination of trichloro-
ethylene vapor and cigarette smoke for 15 days had
reductions in surfactant secretion to a level far below
that found with either agent alone. Potentially impor-
tant chemical-chemical interactions in the lung may
also occur between an inhalant and a bloodborne
agent. It was recently shown that this may not
only produce acute lung damage, but may also lead
to the development of chronic pathologic conditions
(15).
Direct interactions between two chemicals may
on occasion mitigate rather than enhance toxicity.
Ammonia is known to reduce H2SO4 mist toxicity,
as was first demonstrated in guinea pigs (16). Anec-
dotal evidence of ammonia protecting against S02 is
given in an account of the London fog disaster of
1952 (17). Animals housed in pens that had not been
regularly cleaned suffered far less pulmonary toxicity
than those kept in clean surroundings. Presumably,
the ammonia fumes emanating from the animal waste
in the dirty pens combined with the SO2 in the im-
mediate atmosphere to form ammonium sulfate which
is much less toxic than either SO2 or H2SO4. Atten-
tion must be paid to this neutralizing effect of NH3 in
long-term inhalation studies (18).
Phalen and co-workers (19) examined the effects of
several aerosols (ammonium sulfate, ferric sulfate
and H2SO4) in combination with 03 on the rates of
tracer particle clearance in rats. It was found that
the effects of the aerosols combined with 03 were
qualitatively similar to those observed with 03 alone.
However, the combination often produced effects quanti-
tatively less than those observed with 03 alone. A
reduction in the lethality of nitric acid fumes and
an increase in the lethality of formaldehyde vapors
were observed during simultaneous exposure of mice
to certain aerosols (20). In another gas-aerosol inter-
action, the toxicity of NaOH aerosols was lessened
by reaction with ambient CO2 and water vapor
resulting in the formation of the much less alkaline
and toxic sodium carbonate. The damage to the
deep lung was further lessened by the changes in
aerodynamic behavior brought about by the new
size and density of the particles which helped to limit
deposition to the upper respiratory tract and nasal
passages (21).
In attempts to document unequivocally interactions
between inhaled gases in humans somewhat ambiguous
results were obtained. Linn and co-workers (22)
did not find significant alterations in pulmonary function
in humans exposed to a mixture of NO2 and SO2
compared to exposure to each gas alone, although
several nonspecific symptoms (e.g., headache, cough,
substernal irritation) were reported more frequently
with the mixture. When humans were exposed to
a combination of SO2 and 03, a much greater decline
in maximum expiratory flow was recorded than found
with exposure to either gas alone (23). Similar changes
in pulmonary function were not found in later studies
with this combination of pollutants (24-26). These con-
flicting results may be at least partially explained by
interexperimental variations in levels of particulates
within the exposure chamber, and differences in tem-
perature and humidity. In fact, a less severe decline
in ventilatory function was observed when some of
the same subjects used in the Hazucha and Bates
study (23) were exposed under stricter conditions
of particulate, temperature, and humidity control (26).
Direct reaction between two chemicals may thus
modify the response following inhalation of agents or
following simultaneous exposure to an inhalant and a
bloodborne agent. Thebiologicalresponse canbeincreased
or mitigated. However, it must be pointed out that
studies on interactions between air pollutants in the
laboratory setting may differ from the actual interac-
tions which may occur in man in the outside world. This
is particularly true when, in experiments, natural
"filtering" processes are circumvented. The role of the
nasal-pharyngealregioninabsorbingwater-solublecom-
pounds such as SO2 and ammonia must be remembered
because this may play a role when particulates are
present to combine with these agents (9). It must also
be kept in mind that with a small number of human
subjects in a given study, one may fail to include
individuals such as asthmatics or healthy humans who
breathe oronasally at rest (27-29). These people are or
may be unusually sensitive to airpollutants. Any results
obtained in a limited study may underestimate the risk
to sensitive individuals. Forexample, asthmatics develop
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broncho-constriction at considerably lower concentra-
tions ofinhaled SO2than healthy people without asthma
(29). This makes it somewhat difficult to extrapolate
from laboratory studies and to estimate fully and
precisely the risk of multichemical exposure to all
segments of the population.
Oxygen Free Radicals. There is evidence to show
that pulmonary oxygen toxicity in experimental ani-
mals is greatly enhanced bythe concomitant presence of
several agents inthe lung. Examples arethe dipyridylium
herbicides paraquat and diquat (30-32), the antibacte-
rial drug nitrofurantoin (33), and disulfiram (34). A
characteristic feature ofthe interaction between 02 and
these chemicals is the greatly accelerated and increased
mortality which is preceded and accompanied by the
development of massive intraalveolar and perivascular
edema.
It is thought that both the dipyridylium herbicides
and nitrofurantoin in the presence of oxygen undergo
cyclical reduction and oxidation, with concomitant con-
sumption of NADPH and generation of large amounts
of superoxide anion. Evidence for NADPH depletion
and superoxide anion formation has been found both in
iii vitro and in vivo conditions (33-38). The superoxide
anion would then undergo further transformation to
such reactive species as singlet oxygen, hydrogen
peroxide and hydroxyl radicals.
Paraquat is actively taken up by the lung, whereas
diquat is not (39). Given at equimolar doses, about 5 to
10 times as much paraquat as diquat is found in rat lung
afew hoursfollowingintravenousinjection (38). However,
the lethal interaction between oxygen and paraquat or
diquat is not necessarily proportional to the tissue
concentrations of the herbicides. With low doses (5
mg/kg IV) the LT50 (time for 50% ofthe animals to die)
in 100% 02 iS considerably shorter for paraquat com-
pared to diquat. However, following injection of 80
mg/kg, diquat-treated animals die sooner. If paraquat
and diquat are given at equitoxic doses (20 mg/kg with
an LT50 in 100% 02of11-12 hrforboth compounds), rats
treated with diquat are much more susceptible to 40%
02 than are rats treated with paraquat (32). Diquat has
a lower redox potential than has paraquat (40), and
diquat radicals have been shown to cycle more rapidly in
tissuehomogenates than paraquatradicals (41). Exacer-
bation of pulmonary injury caused by simultaneous
exposure to paraquat or diquat and to 100% oxygen
depends thus not only on amount of the toxic agent
present, but also on rates offormation ofthe ultimately
toxic molecular species.
A similar mechanism was postulated for the inter-
action between 02 and nitrofurantoin (33). Increased
destruction ofoxygen free radicals by enzymatic scaven-
gers should therefore abolish or at least mitigate
oxygen toxicity. There is strong evidence to suggest
that endogenous superoxide dismutase (SOD) (mito-
chondrial and cytoplasmic) plays a key role in protecting
the lung against oxygen toxicity by dismutating singlet
oxygen to hydrogen peroxide (42). Administration of
exogenous SOD might be a rational procedure to
counteractoxygentoxicity. Whileseveralinvitrostudies
have indicated SOD to be an effective antidote, results
of in vivo experiments are somewhat conflicting.
McLennan and Autor (43) reported that continuous
delivery of SOD at a rate of 140 units/hr protected rats
exposed to95%02 against pulmonary damage. Continu-
ous delivery of the SOD was achieved with osmotic
minipumps implanted into the peritoneal cavity. On the
other hand, Crapo et al. (44) failed to protect rats
against the lethal effects of 100% 02 when SOD was
injected or administered as an aerosol. It was also not
possible to protect mice against potentiation of butyl-
ated hydroxytoluene (BHT)-induced lung damage by
70%02 with a continuous, 7-day-long infusion of SOD,
given IP or SC by use ofan osmotic minipump at a rate
of 62 units/hr (Hakkinen, unpublished observations).
SOD reportedly was used with some success to protect
animals under other experimental conditions where
oxygen free radicals are thought to be ultimately
responsible for injury, such as whole-body or localized
skinX-irradiationorinacuteparaquatpoisoning(45-49).
However, administration of 10 mg/kg ofSOD IP twice a
day to rats deficient in vitamin E for 3 days before and 3
days after paraquat failed to prevent paraquat toxicity
(50). While there appears to be- no question that
endogenous SOD is a key enzyme in defending lung
tissue against oxygen toxicity (42,51), it appears to be
more difficult to achieve effective levels of exogeneous
SOD at the target sites of oxygen toxicity. This is, of
course, a common problem in all attempts to provide
antidotal therapy based on direct interactions between
a toxic molecular species and compounds designed to
neutralize or to deactivate them. More research in this
important area is needed, particularly since it has been
found that other free radical scavengers such as cyste-
amine and cysteine may give some protection against
free radical-mediated lung injury. Continuous infusion
ofcysteamine hydrochloride to rats exposed to 100% 02
reduced pulmonary edema, protected against oxidation
of the lung sufhydryl pool, prolonged survival and
decreased mortality (52).
Competition between Agents at Cellular
Targets, Storage and Uptake Sites
A great deal of information is now available on the
pulmonary uptake, metabolism and disposition of
endogenous and exogenous chemicals. The role of the
lung as a metabolic organ is now well recognized (53).
Many of those studies have been done with isolated
perfused lung preparations. It is now evident that
competition between chemicals at sites of uptake and
metabolism plays an important role in drug metabolism
and disposition and in interaction between exogenous
and endogenous agents (54).
The naturally occurring amines 5-hydroxytryptamine
(5-HT, serotonin) and norepinephrine accumulate in the
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lung against a concentration gradient (55). It has been
shown that uptake of 5-HT occurs by an energy-
requiring Na+-dependent mechanism; the site ofuptake
is the capillary pulmonary endothelium. Ouabain and
imipramineinhibit5-HTuptake (55, 56). Theanorexigenic
agent chlorphentermine, which itself accumulates in
lung tissue, may decrease both the uptake of 5-HT by
the pulmonary endothelial cells and also its subsequent
metabolism by monamine oxidase (57). Since both
chlorphentermine and 5-HT are taken up at least
partially by Na-dependent transport mechanisms, it is
likely that chlorphentermine inhibits 5-HT uptake by
occupying sites on a carrier molecule. It has also been
suggested that chlorphentermine liberates 5-HT from
storage sites (58). Since anorexigenic agents such as
aminorex and chlorphentermine have been shown to
produce pulmonary hypertension, it is conceivable that
acombination ofuptakeinhibition, decreasedmetabolism
and release ofstored 5-HT from lung storage sites plays
a role in the etiology of drug-induced pulmonary
hypertension (57).
Severalexogenousbasicamines, suchasd-propranolol,
methadone and phenoxybenzamine, are concentrated in
the lung (54). Compounds with similar physicochemical
characteristics may inhibit their uptake and binding or
accelerate the release of agents already taken up (59).
Anattemptwasmadetoexploitthepossiblecompetition
between different compounds at recognition sites ofthe
cell membrane for a rational approach to the treatment
ofparaquat poisoning. It was found that several drugs,
among them propranolol and endogenous amines such
as 5-HT and histamine, inhibit uptake of paraquat by
lung slices in vitro (60). However, propranolol injection
1 hr following paraquat did not protect rats (49). In
human cases of paraquat poisoning the benefits of
propranolol treatment remain ambiguous (61, 62).
There are, however, other examples which show that
competition between molecules at sites of uptake or
metabolism in the lung prevents or at least alleviates
toxicity. Treatment of animals with SKF-525A or with
piperonyl butoxide protects mice and rats against Clara
cell necrosis produced by 4-ipomeanol, 3-methylfuran
and CC14 (4) or against alveolar Type I cell damage by
BHT (63). All these compounds presumably require
metabolic conversion to a reactive intermediate by
mixed function oxidases prior to causing cell death.
Since both SKF-525A and piperonyl butoxide or a
metabolite thereof are competitive inhibitors for these
agents at cytochrome P-450, toxicity is prevented.
An interesting observation is that mice kept on red
cedar shavings can be completely protected against
BHT-induced lung damage (64). It has been known for
some time that certain wood beddings induce drug-
metabolizing enzymes in the liver and may decrease the
toxicity ofcertain compounds by enhancing pathways of
inactivation or detoxification (65). Protection against
BHT damage in lung could thus be caused by enhanced
detoxification of BHT by pulmonary mixed function
oxidases. Inhalation of inducing agents increases pul-
monary aryl hydrocarbon hydroxylase activity to peak
activity within a few hours, whereas intraperitoneal
injection of inducers usually results in much slower
increases in enzyme activity in lung (66,67). However,
mice are protected against BHT toxicity not only when
they are placed on red cedar shavings shortly before
BHT injection, but even ifplaced upon it up to 3 hr after
BHT (64). This makes it unlikely that protection against
BHT damage is a result of enhanced detoxification
following enzyme induction. Rather, itmustbe assumed
that volatile compounds emanating from the bedding
and inhaled by the animals act as competitors for BHT
at its site of uptake or biotransformation in the lung.
These compounds are in all likelihood certain cedar
terpenes, such as cedrol, or sesquiterpenes (64). The
experiments done by Malkinson (64) show that it is
possible to prevent pulmonary toxicity caused by a
bloodborne agent by inhalation of suitable antagonists
or competitors even after administration of the toxic
agent. Efforts should be made to determine whether
such a mechanism of interaction can be exploited to
protect lung against other toxic agents.
Interactions Resulting from
Exposures Separated in Time
Acute diffuse lung injury caused by many toxic
inhalants and bloodborne agents often produces pro-
found changes in cellular structure and function (68).
This in turn, may modify the biological response to a
subsequent exposure to another toxic agent. As a
consequence, toxicological interactions may also play a
role in producing or protecting against lung injury even
iftheexposuretotwoormoreagentsisnotsimultaneous,
but separated in time.
Interactions Where the Response to a Sec-
ond Agent is Modified
Induction ofPulmonaryMixedFunction Oxidases.
Induction of hepatic microsomal metabolism greatly
increases the toxicity of several compounds, such as
CC14 or acetaminophen, whereas the untoward effects
of other chemicals such as 2-acetylaminofluorene or
aminoazo dyes may be mitigated or abolished (69-72).
Similarly, enzyme induction in lung by one agent may
modify the response produced by a second agent (4,73).
However, relationships among increased biotransfor-
mation, formation of active metabolites and enhance-
ment ofpathways ofdetoxification are often complex. It
must also be kept in mind that the organ involved in the
formation ofthe active and presumably toxic metabolite
of a compound may not always be the only site of
toxicity. In the mouse, bromobenzene toxicity in lung
and kidney appears tobe mediatedthrough formation of
bromobenzene epoxide in the liver. Phenobarbital pre-
treatment did not increase mixed function oxidase
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activity in mouse lung or kidney, but aggravated toxic-
ityandalsotheamountofcovalentlyboundbromobenzene
metabolitesinbothorgans. Pretreatmentwithpiperonyl
butoxide had the opposite effect (73). The data suggest
that bromobenzene is converted in the liver to an active
intermediate ofsufficient stability toreach othertissues
via the bloodstream and to cause damage at sites
distant from its original formation. It is important to
realize that toxicological interactions may result in
shifts in target organs and this may affect pulmonary
toxicity.
This has also been documented in studies with
4-ipomeanol and 3-methylfuran. Evidence showing that
both these compounds undergo metabolic activation to
highly reactive intermediates is discussed elsewhere in
this volume. In both mice and rats 4-ipomeanol pro-
duces acute Clara cellnecrosis. Pretreatment ofanimals
with3-methylcholanthrene, aninducer ofmixed-function
oxidases inboth liver and lung, increases hepatotoxicity
and a greater amount ofcovalently bound metabolite is
found in the liver. At the same time, pulmonary toxicity
is diminished or even abolished. Toxicity can only be
modulated by 3-methylcholanthrene in mouse strains
where arylhydrocarbon hydroxylase isinducible, whereas
no shifts intoxicity are produced innoninducible strains
(4). A second enzyme inducer, phenobarbital, did not
shift4-ipomeanoltoxicityfromlungtoliver, butdecreased
overall toxicity and lung damage in rats (74). An
interesting observation is that pretreatment with small
doses of 4-ipomeanol makes rats resistant to a subse-
quent otherwise lethal dose ofthe same compound. This
is not a unique observation; mice can be made resistant
to CC14 hepatotoxicity with small doses of CC14 (75).
Destruction ofcytochrome P-450 by the first small dose
may prevent the liver or lung from converting the
second dose ofan agenttoitsultimatelytoxicmetabolite.
Pretreatment with 4-ipomeanol also produces resis-
tance to other toxic furan compounds and to the
edematagenic agent a-naphthylthiourea (ANTU). How-
ever, ANTU pretreatment will not protect against
4-ipomeanol (76), although ANTU has been shown to
inhibit pulmonary mixed function oxidases (77). The
reasons for this are unknown but may be due to the
apparently different types of lung injury produced by
ANTU and 4-ipomeanol and the different mechanisms
of toxicity (4).
Data on modulation oflung injury by agents altering
the activity ofpulmonary mixed function oxidases are,
at present, much less complete than data on modulation
of hepatotoxicity by such agents. This may be because
the role of biotransformation in the pathogenesis of
toxic lung damage has only recently been appreciated.
Also, quantitative information on primary lunginjury is
less readily obtained than on toxic liver injury.
Fromthe examples discussed itis obviousthat agents
which enhance or destroy the activity of pulmonary
mixed function oxidases may influence toxic response.
However, it cannot be anticipated a priori whether
toxicity of a given compound will be enhanced or
mitigated, since both detoxifying pathways and toxify-
ing ones may be stimulated. Enzyme inducers also may
shift toxicity from one organ to another. Effects seen in
one species cannot necessarily be extrapolated to other
species, as in the case ofbromobenzene toxicity in rats
and mice (73).
Enzyme inducers represent one example where we
find that pulmonary injury is modified by two agents,
evenifexposure occurs separated intime. The temporal
sequence of exposure is important because inducers
must be given before the second challenging agent; if
the exposure is reversed, no interactions occur.
Induction of Tolerance. It has been mentioned
before that small doses of4-ipomeanol, ANTU or BHT
afford protection against a second, larger dose of the
same agents. The phenomenon can be called tolerance
and, as such, has been known for a long time in
pulmonary toxicology (78). Some newer observations
offer additional insight into this particular form of
interaction.
The cells lining the alveolar and capillary walls
undergo profound morphological changes when exposed
to hyperoxia. Exposure of adult rats to 100% 02 until
death destroys almost half of the capillary endothelial
cells. In animals exposed to 85% 02, about 40% of the
capillary endothelial cells are destroyed. The endothe-
lial cells that survive 7days in 85% 02 showhypertrophy
and from this time on they no longer become damaged
even if 85% 02 exposure is continued (79). Activities of
glucose-6-phosphate dehydrogenase (G6PD), catalase
(C) and the mitrochondrial and cytosolic superoxide
dismutases are also increased by exposure to 85% 02
This increased activity ofpulmonary enzymes coincides
with the development of "tolerance' Animals made
tolerant by prior exposure to 85% 02 for 5 to 7 days are
able to survive indefinitely at 100% 02 (51,79-83).
Inanotherstudyof02tolerance, Crapoandco-workers
(82, 84) have shown that rats made tolerant to 100% @2
by prior exposure to 85% 02 exhibited partial cross-
tolerance to 75 ppm NO2. Rats made tolerant to 75 ppm
NO2 by prior exposure to 25 ppm NO2 did not show
significant cross-tolerance to 100% 02. As mentioned
above, 02 tolerance coincided with increased SOD
activity. However, the development of NO2 "tolerance"
did not result in a significant increase in pulmonary
SOD activity, although catalase activity was signifi-
cantly increased. This may explain why NO2 pretreat-
ment fails to give cross-protection against 100% 02.
Differences indiffusionof02and NO2intothe deeplung
and resulting differences in distribution of lesions
produced by the two agents may play a role in the
development of tolerance and cross-tolerance found
between these two gases.
Finally, rats exposed to 03 (approx. 0.8 ppm for 7
days) have been shown to develop cross-tolerance to
96-98%02. 03-exposedanimalshad significantincreases
in lung superoxide dismutase, glutathione peroxidase
(GP) and glucose-6-phosphate dehydrogenase (G6PD)
activities by day 7 of 03 exposure and became tolerant
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to 03. Survival ofthese animals was markedly increased
when exposed to 96-98% 02 (85). Thus, the oxidant
component ofphotochemical smog that causes a signifi-
cant increase in SOD activity (03) produces cross-
tolerance to hyperoxia, while NO2, which does not
elevate SOD activity, shows no cross-tolerance to subse-
quent 02 exposure.
Tolerance to oxygen may also be produced by the
bacterial lipopolysaccharide, endotoxin. This phenome-
non has been well documented (86-89). Although the
mechanism ofprotection remains unclear, small doses of
endotoxin given to oxygen-exposed adult rats have been
shown to significantly increase survival and decrease
lung fluid accumulation ifgiven up to 36 hr followingthe
onset of exposure to 95% oxygen. Unlike the situation
where protection against 100% oxygen is achieved by
pretreatment with lower oxygen concentrations, endo-
toxin-induced protectionrequiresnopretreatmentsched-
ule (88). Interestingly, endotoxin also protects against
lung injury produced by the bloodborne edematogenic
agent thiourea (90).
The biochemical response of the endotoxin-treated
adult rat lung exposed to hyperoxia is very similar to
that observed in untreated neonatal animals. Whereas
untreated adult rats upon exposure to 100% 02 show no
increase in antioxidant enzyme levels (SOD, glutathione
peroxidase andcatalase), arapidandsignificantincrease
occurs in the lungs of neonatal animals and endotoxin-
treated rats (89, 91-93). However, in endotoxin-treated
adult mice, exposure to oxygen produced neither an
increase in lung antioxidant enzyme norprotection from
oxygen toxicity (87).
A potentially important form of tolerance induction,
which might directly relate to human toxicology, was
found with the anticancer drugcyclophosphamide. Mice
given a small "priming" dose ofcyclophosphamide show
increased survival following a subsequent larger dose.
Lung damage, as measured by increased ventilation
rate, was significantly reduced if the priming dose (50
mg/kg) was given either 7 or 14 days before 250 mg/kg
of cyclophosphamide. However, if the animals were
"primed" on the day prior to the large dose ofthe drug,
lung damage seemed to be enhanced (94). The mech-
anism(s) by which cyclophosphamide pretreatment
enhances or mitigates lung toxicity remains to be
elucidated. It is tempting to speculate that the cell
types proliferating in the lung at the given time
following cyclophosphamide-induced injury determine
the reaction to the second insult. Collis and co-workers
(94) have observed acute interstitial pneumonitis and
alveolar Type II cell hyperplasia one week after 300
mg/kgcyclophosphamide. FurtherType IIcellhyperpla-
sia was observed 2 weeks following cyclophosphamide.
We found that treatment of mice with 200 mg/kg
cyclophosphamide resultedinanincreasein14C-thymidine
incorporation into pulmonary DNA between days 4 and
21 after treatment with one peak occurring at day 7
(95). The correlations of these increases in thymidine
incorporation with proliferation of specific cell types
andwithinductionoftolerance remaintobeestablished.
However, the observation by Collis et al. (94) suggests
that following treatment with a small dose of pulmo-
narytoxin asecond large dose mayproduce increased or
decreased lesions, depending upon the time interval
between administration. This emphasizes the impor-
tance of temporal relationships.
Finally, it must be mentioned that in numerous
studies an attempt was made to protect animals against
oxidant-induced lung injury by treatment with dietary
antioxidants such as vitamin E, vitamin K, selenium
and other agents. Such treatments may produce bio-
chemical changes in the lung which, in turn, may alter
the response to oxidant exposure. Much ofthe datahave
recently been reviewed (83).
Interactions Where the Development of
Lesions Produced by a First Agent Is
Enhanced
Administration of inducers of mixed function oxi-
dases or induction of tolerance alters lung metabolism
and possibly lung structure in such a way that the
response toasecond, challengingtoxic agentisenhanced
or mitigated. However, it is also possible to amplify
the lesions produced by a first agent with exposure to
an otherwise nontoxic dose of a second agent.
A single dose of the antioxidant BHT causes acute
lungdamageinmice. Theoriginalobservation wasmade
in 1972 (96) and has since been confirmed in several
laboratories (64,97-101). Diffuse lung lesions develop
after oral or intraperitoneal administration ofBHT and
are dose-dependent (102,103). All mouse strains exam-
ined so far are susceptible to BHT (64,98,102). Other
laboratoryrodents, however, particularlyrats, hamsters
and rabbits, do not develop lung damage after BHT
(63,98,104).
The morphologic and biochemical changes in mouse
lung produced by BHT are very similar to the general
pattern of primary pulmonary injury caused in many
species by toxic agents (68). They can be summarized as
follows: within the first 24 hr, many Type I alveolar
epithelial cells show acute cytoplasmic edema undergo
necrosis and eventually disintegrate, leaving behind a
denuded basement membrane. Type II alveolar epithe-
lial cells are not visibly damaged by BHT. They begin to
proliferate; peak mitotic activity is seen on days 2 to 4
after BHT at which time as many as 80% ofall dividing
cells in the alveolar zone are type II epithelial cells.
Around days 4 and 5 after BHT, secondary damage to
the capillary endothelial cells becomes apparent (105).
Interstitial cells appear not to become damaged by
BHT, but rather proliferate and invade the empty areas
left by damaged cells. Macrophages show extensive
phagocytic activity and become filled with cell debris.
Five to seven days after BHT, epithelial cell prolifera-
tion has largely subsided and most proliferating cells
are capillary endothelial and interstitial cells (105,106),
Two weeks after BHT, scattered alveolar wall hyper-
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cellularity and occasional intraalveolar macrophages
can still be seen by microscopy whereas at 3 weeks after
BHT the lungs look virtually normal again (107).
Thus BHT initially produces a diffuse lung lesion.
More important, cell proliferation following the initial
insult proceeds in an orderly way; epithelial cells divide
first, endothelial and interstitial cells somewhat later
(106). Since earlier work had shown that oxygen
inhibits cell division in the lung even in concentrations
which do not damage a normal lung (108), the effects of
oxygen on BHT damaged lungs were studied. Detailed
analysis of time effect and dose effect suggested that
exposure to 40 to 100% 02 for as few as 16-24 hr would
inhibit division of epithelial cells in lung, but not of
capillary endothelial or interstitial cells (109). From
these observations it was predicted that exposure of
animals to oxygen early after BHT-induced lung injury
would destroy epithelial cells while allowing fibroblasts
to proliferate. The result should be fibrosis.
This prediction was found to be true. Ifanimals were
treated with BHT and placed immediately into an
atmosphere of 50 to 80% 02, extensive and diffuse
pulmonary fibrosis developed within 2 weeks. In ani-
mals treated with BHT alone, total lunghydroxyproline
was somewhat elevated, whereas in animals exposed to
70%02, no abnormal accumulation was found. However,
the combined effect of BHT and 02 were synergistic
(107). Severity of fibrosis was found to be determined
by the concentration of oxygen, duration of oxygen
exposure, and extent of initial lung damage caused by
BHT (110). Fibrosis developed in BHT damaged lungs,
not only following exposure to oxygen, but also following
treatment with other agents which interfere with cell
profliferation in lung, such as a low dose of X-rays
(50-200 rad) (111) and high doses ofprednisolone (112).
Prednisolone has recently been shown to interfere with
epithelial cell proliferation in lung (101).
Exposure to 70% oxygen also produces fibrosis if
animals are pretreated with lung-toxic agents other
thanBHT. Methylcyclopentadienylmanganesetricarbonyl
(MMT) is an octane enhancer that is added to unleaded
gasoline. It causes diffuse alveolar damage followed by
cell proliferation in mice, rabbits, rats and hamsters
following either topical, intraperitoneal or oral admini-
stration (113-115; Hakkinen, unpublished observations).
In experiments similar to those done with BHT and
oxygen, total lung collagen content in mice was signifi-
cantly increased if MMT-treated mice were placed in
70% oxygen for 6 days followinginjection (110). We have
also found statistically significant increases in total lung
hydroxyprolinecontentifcyclophosphamide-, bleomycin-
or cadmium chloride aerosol-treated mice are placed
immediately into 70% oxygen for 5 to 9 days (95;
Hakkinen, unpublished observations).
In all these experiments, oxygen alone, given in
concentrations up to 80% for a maximum of 6 days, did
notproduce anysignificantfibrosis. However, itenhanced
greatly the development of fibrosis in previously dam-
aged lungs. In this context it is interesting to note that
intermittent exposure to > 95% 02 (48 hr in oxygen,
followed by 24-hr cycles of air alternating with oxygen)
results in marked accumulation ofhydroxyproline in rat
lung (116). This might represent another example of
fibrosis resulting from initial injury (first exposure) and
subsequent interference with tissue recovery subse-
quent to intermittent exposures.
Acute lung damage caused by a variety of chemicals
belonging to different classes and presumably having
different mechanisms of initial toxicity may thus be
greatly enhanced by a second toxic agent which inter-
feres with recovery ofthe damaged alveolar tissue. The
result is a quantitatively different lesion, abnormal
accumulation of interstitial collagen. Following one
acute episode ofinteraction between two such agents, a
lesion develops which has been found to persist from 6
months up to 1 year (117). It must be emphasized that
this only occurs if an acutely damaged lung is exposed
to the second toxic agent within afew days. Exposure to
oxygen or to X-rays after epithelial cell proliferation in
lung will not produce fibrosis (107, 110, 111). The
timing of exposure to two agents is thus critically
importantinthedevelopmentofatoxicologicalinteraction.
Aggravation of the response to a first agent in the
lung by a second agent is thus an important example of
toxicological interactions. It might explain two well-
known human pathologic conditions: development of
adult respiratory distress syndrome where it is sus-
pected that oxygen therapy aggravates the initial lung
damage (118), and rapid development of diffuse pulmo-
nary fibrosis in patients treated concomitantly with
chemotherapeutic agents and irradiation of the thorax
(119). In 29 patients treated for oat cell carcinoma of
the lung with combination chemotherapy consisting of
bleomycin, adriamycin, cyclophosphamide andvincristine,
no pulmonary complications arose whereas pulmonary
fibrosis was a significant problem when the regimen
was combined with thoracic irradiation (120). An inter-
action between anticancer drugs and X-ray irradiation
wasalsofoundinmice. Administrationofeitheradriamycin
(14 days before), bleomycin (13 days before) or cyclo-
phosphamide (either 3 hr before or 2 hr after) before
thoracicirradiation decreased thesurvivaltimesobserved
(121).
Conclusions
An attempt was made to discuss the possible role of
toxicological interactions in the pathogenesis of acute
and chronic lunginjury. There is no question that under
many circumstances exposure ofthe lung to two poten-
tially toxic agents will result in a much more severe
lesion than would exposure to each single agent alone.
It is also possible that lung damage may be mitigated or
even prevented if two agents cancel out each others
action.
Interactions may occur ifexposure is simultaneous or
separated in time. In both cases, the nature and
severity of the pulmonary lesions can often be pre-
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dicted by knowing the chemical properties and mecha-
nism ofaction ofthe two agents. However, ifexposure is
not simultaneous, an additional important factor needs
to be considered: the temporal sequence ofexposure. In
all instances where the response to a second, challeng-
ing agent is modified by a first agent, the sequence of
exposure cannot be reversed, and ifit is, no interaction
occurs. The only possible exception is induction of 02
tolerance by endotoxin. On the other hand, whenever a
second agent amplifies the response to a first agent,
such as in animals treated with BHT and then exposed
to oxygen or X-rays, an abnormal biological response is
only seen if the exposure to the second agent occurs
within a critical period following the initial injury.
Finally, it is realized that the classification of the
different examples of toxicological interactions often
was arbitrary and perhaps artificial. However, it is
hoped that this general framework will help the further
study and analysis of the role of interactions in a
systematic way.
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